- Centene Corporation Reports 2014 Second Quarter Results & Raises Guidance - -- Diluted earnings per share (EPS) from continuing operations of $0.79 --

-- $0.95 excluding $0.16 impact from the Health Insurer Fee --

ST. LOUIS, July 22, 2014 /PRNewswire/ --  Centene Corporation (NYSE: CNC) today announced its financial results for the quarter ended June 30, 2014.  The following discussions, with the exception of cash flow information, are in the context of continuing operations.

Premium and Service Revenues (in millions)

$

3,741

Consolidated Health Benefits Ratio

88.9%

General & Administrative expense ratio

8.6%

Diluted earnings per share (EPS)

$

0.79

Diluted EPS excluding the effect of the health insurer fee

$

0.95

Total cash flow from operations (in millions)

$

159.4

Michael F. Neidorff, Centene's Chairman and Chief Executive Officer, stated, "The Company delivered strong top and bottom line growth in the second quarter, driven by the ongoing successful execution of our growth and diversification strategy.  We are pleased with the results in the first half of 2014 and have increased our full year guidance to reflect the additional growth and profitability in the business."

Second Quarter Highlights

  • June 30, 2014 at-risk managed care membership of 3,164,500, an increase of 601,100 members, or 23% compared to the second quarter of 2013.
  • Premium and service revenues for the second quarter of $3.7 billion, representing 49% growth compared to the second quarter of 2013.
  • Health Benefits Ratio of 88.9% for the second quarter of 2014, compared to 88.4% in the second quarter of 2013. 
  • General and Administrative expense ratio of 8.6% for the second quarter of 2014, compared to 8.9% in the second quarter of 2013. 
  • Operating cash flow of $159.4 million for the second quarter of 2014, or 3.3 times net earnings.
  • Diluted earnings per share of $0.79, or $0.95 excluding a $0.16 impact associated with the health insurer fee, compared to $0.71 in 2013.

Other Events

  • In July 2014, our Illinois subsidiary, IlliniCare Health, began operating under a new five-year contract with the Cook County Health and Hospitals System (CCHHS) to perform third party administrative services to members enrolled in the CountyCare program, as well as care coordination, behavioral health, vision care and pharmacy benefit management services.
  • In July 2014, our Mississippi subsidiary, Magnolia Health, began operating as one of two contractors under a new statewide managed care contract serving members enrolled in the Mississippi Coordinated Access Network program.  The program provides for membership expansion beginning in late 2014.
  • In July 2014, we completed the transaction whereby Community Health Solutions of America, Inc. (CHS) assigned its contract with the Louisiana Department of Health and Hospitals under the Bayou Health Shared Savings Program to our subsidiary, Louisiana Healthcare Connections. 
  • In July 2014, we completed the purchase of a noncontrolling interest in Ribera Salud S.A., a Spanish health management group. Centene will be a joint shareholder with Ribera Salud S.A.'s remaining investor, Banco Sabadell.
  • In April 2014, we issued $300 million 4.75% Senior Notes due May 2022 and entered into interest rate swap agreements, converting the Senior Notes to a floating rate of interest at the three month LIBOR rate plus 2.27%.

Accreditations & Awards

  • In June and July 2014, our Illinois subsidiary, IlliniCare Health, our Louisiana subsidiary, Louisiana Healthcare Connections, our Kansas subsidiary, Sunflower Health Plan, and our Washington subsidiary, Coordinated Care, all received accreditation from the National Committee for Quality Assurance.
  • In June 2014, FORTUNE magazine announced Centene's position of #251 in its annual ranking of America's largest companies by revenue.
  • In June 2014, Centene was added to the Russell 1000 index and Russell Midcap index.
  • In May 2014, at the Case In Point Platinum Awards, Centene and its subsidiaries were honored with awards in five categories: Disease Management/Population Health, Managed Care, Long-Term Care, Pediatric Case Management and Wellness/Prevention.
  • In May 2014, our Georgia subsidiary, Peach State Health Plan, received the 2014 National Environmental Leadership Award in Asthma Management from the U.S. Environmental Protection Agency.

The following table sets forth the Company's membership by state for its managed care organizations:


June 30,


2014


2013

Arizona

7,000


23,200

Arkansas

31,100


California

131,100


Florida

313,800


216,200

Georgia

373,000


316,600

Illinois

29,500


18,000

Indiana

200,500


200,000

Kansas

146,100


137,500

Louisiana

148,600


153,700

Massachusetts

47,200


15,200

Minnesota

9,400


Mississippi

97,400


77,300

Missouri

58,700


58,800

New Hampshire

39,500


Ohio

225,900


156,700

South Carolina

101,800


88,800

Tennessee

21,300


Texas

921,500


960,400

Washington

193,800


67,600

Wisconsin

67,300


73,400

Total

3,164,500


2,563,400

At June 30, 2014, the Company served 155,800 Medicaid members in Medicaid expansion programs in California, Massachusetts, Ohio and Washington included in the table above. The Company also served 182,200 members at June 30, 2014 under its behavioral health contract in Arizona, compared to 157,100 members at June 30, 2013.

The following table sets forth our membership by line of business:


June 30,


2014


2013

Medicaid

2,385,500


1,953,600

CHIP & Foster Care

261,800


273,200

ABD & Medicare

329,700


289,800

Health Insurance Marketplace (HIM)

75,700


Hybrid Programs

17,000


22,400

Long Term Care (LTC)

53,500


24,400

Correctional services

41,300


Total

3,164,500


2,563,400

The following table identifies our dual eligible membership by line of business.  The membership tables above include these members.


June 30,


2014


2013

ABD

89,300


71,400

LTC

41,800


16,600

Medicare

8,200


5,700

Total

139,300


93,700

Statement of Operations: Three Months Ended June 30, 2014

  • For the second quarter of 2014, Premium and Service Revenues increased 49% to $3.7 billion from $2.5 billion in the second quarter of 2013.  The increase was primarily as a result of the expansion in Florida, growth in the AcariaHealth business, the addition of the California contract, the expansion in Ohio and our participation in the Health Insurance Marketplaces.
  • Consolidated HBR for the second quarter of 2014, was 88.9%, compared to 88.4% in the same period in 2013, reflecting an increase in higher acuity membership.  Consolidated HBR decreased from 89.3% in the first quarter of 2014 due to normal seasonality.
  • The following table compares the results for new business and existing business for the quarters ended June 30,:

2014


2013

Premium and Service Revenue




New business

26%


18%

Existing business

74%


82%





HBR




New business

91.8%


90.4%

Existing business

87.9%


88.0%

  • Consolidated G&A expense ratio for the second quarter of 2014 was 8.6%, compared to 8.9% in the prior year.   The year over year decrease reflects the leveraging of expenses over higher revenue in 2014.  The 2013 G&A expense ratio also includes the impact of $0.07 per diluted share of AcariaHealth transaction costs which increased the 2013 G&A expense ratio by approximately 20 basis points.
  • Earnings from operations were $92.7 million in the second quarter of 2014 compared to $68.7 million in the second quarter of 2013.  Net earnings attributable to Centene Corporation were $47.2 million in the second quarter of 2014, compared to $40.3 million in the second quarter of 2013. 
  • Diluted earnings per share of $0.79, or $0.95 excluding a $0.16 impact associated with the health insurer fee, compared to $0.71 in 2013.

Balance Sheet and Cash Flow

At June 30, 2014, the Company had cash, investments and restricted deposits of $2,402.5 million, including $50.3 million held by its unregulated entities.  Medical claims liabilities totaled $1,394.1 million, representing 42.9 days in claims payable.  Total debt was $891.0 million, which includes $70.0 million of borrowings on the $500 million revolving credit facility at quarter end.  Debt to capitalization was 35.5% at June 30, 2014, excluding the $71.4 million non-recourse mortgage note.  Cash flow from operations for the three months ended June 30, 2014, was $159.4 million, or 3.3 times net earnings.

A reconciliation of the Company's change in days in claims payable from the immediately preceding quarter-end is presented below:

Days in claims payable, March 31, 2014

42.6

Timing of claim payments

0.3

Days in claims payable, June 30, 2014

42.9


Outlook

The table below depicts the Company's annual guidance for 2014.



Full Year 2014



Low


High

Premium and Service Revenues (in millions)


$

15,000


$

15,500

Diluted EPS


$

3.70


$

3.90

Consolidated Health Benefits Ratio


88.7%


89.2%

General & Administrative expense ratio


8.5%


9.0%

Effective Tax Rate


49.5%


50.5%

Diluted Shares Outstanding (in thousands)


60,000


60,400






The guidance in the table above includes the impact of the Illinois CCHHS contract award, the Louisiana transaction with CHS as well as the acquisition of Ribera Salud.  The diluted EPS guidance for 2014 includes approximately $0.12 of transaction costs associated with CHS and Ribera Salud, as well as $0.06 related to the USMM acquisition recorded in the first quarter.

Conference Call

As previously announced, the Company will host a conference call Tuesday, July 22, 2014, at 8:30 A.M. (Eastern Time) to review the financial results for the second quarter ended June 30, 2014, and to discuss its business outlook.  Michael F. Neidorff and William N. Scheffel will host the conference call. 

Investors and other interested parties are invited to listen to the conference call by dialing 1-866-739-7850 in the U.S. and Canada; +1-412-902-6577 from abroad; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  Or, participants can register for the conference call in advance by navigating to http://dpregister.com/10048780, to receive a dial-in number upon registration.   A webcast replay will be available for on-demand listening shortly after the completion of the call for the next twelve months or until 11:59 PM (Eastern Time) on Tuesday, July 21, 2015, at the aforementioned URL.  In addition, a digital audio playback will be available until 9:00 AM Eastern Time on Wednesday, July 30, 2014, by dialing 1-877-344-7529 in the U.S. and Canada, or +1-412-317-0088 from abroad, and entering access code 10048780.

Other Information

The discussion in the third bullet under the heading "Statement of Operations: Three Months Ended June 30, 2014" contains financial information for new and existing businesses.  Existing businesses are primarily state markets or significant geographic expansion in an existing state or product that we have managed for four complete quarters.  New businesses are primarily new state markets or significant geographic expansion in an existing state or product that conversely, we have not managed for four complete quarters.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures in this release as the Company believes that these figures are helpful in allowing individuals to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently. The Company uses the presented non-GAAP financial measures internally to allow management to focus on period-to-period changes in the Company's core business operations. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals.  Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long Term Care (LTC), in addition to other state-sponsored/hybrid programs, and Medicare (Special Needs Plans).  The Company operates local health plans and offers a range of health insurance solutions.  It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, care management software, correctional systems healthcare, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene.  Subsequent events and developments may cause the Company's estimates to change.  The Company disclaims any obligation to update this forward-looking financial information in the future.  Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses and reserves; competition; membership and revenue projections; timing of regulatory contract approval; changes in healthcare practices; changes in federal or state laws or regulations, including the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act and any regulations enacted thereunder; changes in expected contract start dates; changes in expected closing dates, estimated purchase price and accretion for acquisitions; inflation; provider and state contract changes; new technologies; advances in medicine; reduction in provider payments by governmental payors; major epidemics; disasters and numerous other factors affecting the delivery and cost of healthcare; the expiration, cancellation or suspension of our Medicare or Medicaid managed care contracts by federal or state governments; the outcome of pending legal proceedings; availability of debt and equity financing, on terms that are favorable to us; and general economic and market conditions, as well as those factors disclosed in the Company's publicly filed documents.

[Tables Follow]

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)



June 30,

 2014


December 31,

 2013

ASSETS




Current assets:




Cash and cash equivalents of continuing operations

$

1,199,784


$

974,304

Cash and cash equivalents of discontinued operations

59,013


63,769

Total cash and cash equivalents

1,258,797


1,038,073

Premium and related receivables

610,969


428,570

Short term investments

127,348


102,126

Other current assets

313,946


217,661

Other current assets of discontinued operations

13,826


13,743

Total current assets

2,324,886


1,800,173

Long term investments

996,965


791,900

Restricted deposits

78,442


46,946

Property, software and equipment, net

423,905


395,407

Goodwill

642,613


348,432

Intangible assets, net

81,359


48,780

Other long term assets

107,967


59,357

Long term assets of discontinued operations

26,430


38,305

Total assets

$

4,682,567


$

3,529,300





LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:




Medical claims liability

$

1,394,115


$

1,111,709

Accounts payable and accrued expenses

670,343


375,862

Unearned revenue

22,472


38,191

Current portion of long term debt

6,135


3,065

Current liabilities of discontinued operations

24,642


30,294

Total current liabilities

2,117,707


1,559,121

Long term debt

884,890


665,697

Other long term liabilities

73,897


60,015

Long term liabilities of discontinued operations

451


1,028

Total liabilities

3,076,945


2,285,861

Commitments and contingencies




Redeemable noncontrolling interest

119,671


Stockholders' equity:




Common stock, $.001 par value; authorized 200,000,000 shares; 61,265,156 issued and 57,837,919 outstanding at June 30, 2014, and 58,673,215 issued and 55,319,239 outstanding at December 31, 2013

61


59

Additional paid-in capital

754,637


594,326

Accumulated other comprehensive income:




    Unrealized gain (loss) on investments, net of tax

2,214


(2,620)

Retained earnings

813,765


731,919

Treasury stock, at cost (3,427,237 and 3,353,976 shares, respectively)

(94,512)


(89,643)

    Total Centene stockholders' equity

1,476,165


1,234,041

Noncontrolling interest

9,786


9,398

Total stockholders' equity

1,485,951


1,243,439

Total liabilities and stockholders' equity

$

4,682,567


$

3,529,300




CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share data)

(Unaudited)



Three Months Ended June 30,


Six Months Ended June 30,


2014


2013


2014


2013

Revenues:








Premium

$

3,331,058


$

2,413,312


$

6,401,945


$

4,801,951

Service

410,029


105,599


691,203


138,793

Premium and service revenues

3,741,087


2,518,911


7,093,148


4,940,744

Premium tax and health insurer fee

282,613


91,628


390,440


195,277

Total revenues

4,023,700


2,610,539


7,483,588


5,136,021

Expenses:








Medical costs

2,960,101


2,134,283


5,702,554


4,288,829

Cost of services

365,888


93,300


608,172


118,365

General and administrative expenses

321,042


223,459


616,554


426,755

Premium tax expense

252,669


90,760


330,947


193,735

Health insurer fee expense

31,328



62,655


Total operating expenses

3,931,028


2,541,802


7,320,882


5,027,684

Earnings from operations

92,672


68,737


162,706


108,337

Other income (expense):








Investment and other income

7,252


4,078


11,976


8,342

Interest expense

(8,604)


(7,033)


(15,627)


(13,658)

Earnings from continuing operations, before income tax expense

91,320


65,782


159,055


103,021

Income tax expense

44,874


25,966


79,429


40,657

Earnings from continuing operations, net of income tax expense

46,446


39,816


79,626


62,364

Discontinued operations, net of income tax expense (benefit) of $1,461, $(698), $1,453, and $(350), respectively

1,680


(805)


847


(442)

Net earnings

48,126


39,011


80,473


61,922

Noncontrolling interest

(737)


(473)


(1,373)


(564)

Net earnings attributable to Centene Corporation

$

48,863


$

39,484


$

81,846


$

62,486









Amounts attributable to Centene Corporation common shareholders:








Earnings from continuing operations, net of income tax expense

$

47,183


$

40,289


$

80,999


$

62,928

Discontinued operations, net of income tax expense (benefit)

1,680


(805)


847


(442)

    Net earnings

$

48,863


$

39,484


$

81,846


$

62,486









Net earnings (loss) per common share attributable to Centene Corporation:












    Basic:








      Continuing operations

$

0.82


$

0.74


$

1.41


$

1.18

      Discontinued operations

0.03


(0.02)


0.01


(0.01)

      Basic earnings per common share

$

0.85


$

0.72


$

1.42


$

1.17









    Diluted:








      Continuing operations

$

0.79


$

0.71


$

1.36


$

1.14

      Discontinued operations

0.03


(0.01)


0.01


(0.01)

      Diluted earnings per common share

$

0.82


$

0.70


$

1.37


$

1.13









Weighted average number of common shares outstanding:










Basic

57,758,683


54,529,036


57,622,039


53,449,077

Diluted

59,717,258


56,601,660


59,547,420


55,448,396




CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



Six Months Ended June 30,


2014


2013

Cash flows from operating activities:




Net earnings

$

80,473


$

61,922

Adjustments to reconcile net earnings to net cash provided by operating activities




Depreciation and amortization

42,101


32,928

Stock compensation expense

22,750


16,955

Deferred income taxes

(11,258)


10,715

Changes in assets and liabilities




Premium and related receivables

(160,714)


(71,230)

Other current assets

28,826


(35,879)

Other assets

(28,733)


(38,191)

Medical claims liabilities

284,134


111,625

Unearned revenue

(18,066)


(12,068)

Accounts payable and accrued expenses

160,128


(1,488)

Other operating activities

12,248


5,650

Net cash provided by operating activities

411,889


80,939

Cash flows from investing activities:




Capital expenditures

(41,568)


(30,057)

Purchases of investments

(475,347)


(537,590)

Sales and maturities of investments

221,342


358,971

Investments in acquisitions, net of cash acquired

(94,004)


(66,832)

Net cash used in investing activities

(389,577)


(275,508)

Cash flows from financing activities:




Proceeds from exercise of stock options

3,670


3,867

Proceeds from borrowings

1,145,000


30,000

Payment of long-term debt

(945,892)


(10,118)

Proceeds from stock offering


15,239

Excess tax benefits from stock compensation

1,115


1,113

Common stock repurchases

(4,869)


(1,105)

Contribution from noncontrolling interest

5,407


3,920

Debt issue costs

(6,019)


(3,587)

Net cash provided by financing activities

198,412


39,329

Net increase (decrease) in cash and cash equivalents

220,724


(155,240)

Cash and cash equivalents, beginning of period

1,038,073


843,952

Cash and cash equivalents, end of period

$

1,258,797


$

688,712

Supplemental disclosures of cash flow information:




Interest paid

$

16,439


$

15,170

Income taxes paid

110,118


21,694

Equity issued in connection with acquisition

132,371


75,438




CENTENE CORPORATION

SUPPLEMENTAL FINANCIAL DATA FROM CONTINUING OPERATIONS



Q2


Q1


Q4


Q3


Q2


2014


2014


2013


2013


2013

AT-RISK MEMBERSHIP










Managed Care:










Arizona

7,000


7,100


7,100


23,700


23,200

Arkansas

31,100


16,400




California

131,100


118,100


97,200



Florida

313,800


230,300


222,000


217,800


216,200

Georgia

373,000


331,400


318,700


314,100


316,600

Illinois

29,500


22,400


22,300


22,800


18,000

Indiana

200,500


198,700


195,500


198,400


200,000

Kansas

146,100


145,000


139,900


137,700


137,500

Louisiana

148,600


149,800


152,300


152,600


153,700

Massachusetts

47,200


50,800


22,600


23,200


15,200

Minnesota

9,400


9,400




Mississippi

97,400


85,400


78,300


76,900


77,300

Missouri

58,700


58,100


59,200


58,200


58,800

New Hampshire

39,500


37,100


33,600



Ohio

225,900


181,800


173,200


170,900


156,700

South Carolina

101,800


96,300


91,900


89,400


88,800

Tennessee

21,300


21,100


20,700


20,400


Texas

921,500


904,000


935,100


957,300


960,400

Washington

193,800


151,700


82,100


77,100


67,600

Wisconsin

67,300


70,800


71,500


72,000


73,400

TOTAL

3,164,500


2,885,700


2,723,200


2,612,500


2,563,400











Medicaid

2,385,500


2,169,100


2,054,700


1,953,300


1,953,600

CHIP & Foster Care

261,800


269,200


275,100


274,900


273,200

ABD & Medicare

329,700


300,500


305,300


302,000


289,800

HIM

75,700


39,700




Hybrid Programs

17,000


14,400


19,000


19,600


22,400

LTC

53,500


51,800


37,800


31,600


24,400

Correctional Services

41,300


41,000


31,300


31,100


TOTAL

3,164,500


2,885,700


2,723,200


2,612,500


2,563,400











Specialty Services(a):










Cenpatico Behavioral Health Arizona

182,200


162,700


156,600


160,700


157,100











(a) Includes external membership only.





















REVENUE PER MEMBER PER MONTH(b)

$

359


$

355


$

335


$

328


$

306











CLAIMS(b)










Period-end inventory

745,400


808,500


622,200


698,900


703,400

Average inventory

584,000


555,400


511,700


505,800


510,000

Period-end inventory per member

0.24


0.28


0.23


0.27


0.27

(b) Revenue per member and claims information are presented for the Managed Care at-risk members.











NUMBER OF EMPLOYEES

10,500


9,500


8,800


8,200


7,900

















Q2

2014


Q1

2014


Q4

2013


Q3

2013


Q2

2013

DAYS IN CLAIMS PAYABLE (c)

42.9


42.6


42.4


40.6


41.5

(c) Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.











CASH, INVESTMENTS AND RESTRICTED DEPOSITS (in millions)















Regulated

$

2,352.3


$

2,166.4


$

1,870.6


$

1,612.9


$

1,502.9

Unregulated

50.3


49.3


44.7


37.6


33.8

    TOTAL

$

2,402.6


$

2,215.7


$

1,915.3


$

1,650.5


$

1,536.7











DEBT TO CAPITALIZATION

37.5%


36.5%


35.0%


30.5%


32.9%

DEBT TO CAPITALIZATION EXCLUDING NON-RECOURSE DEBT(d)

35.5%


34.4%


32.4%


27.4%


29.8%

Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity).

(d) The non-recourse debt represents the Company's mortgage note payable ($71.4 million at June 30, 2014).




Operating Ratios:



Three Months Ended

June 30,


Six Months Ended

June 30,


2014


2013


2014


2013

Health Benefits Ratios:








Medicaid, CHIP, Foster Care & HIM

84.7%


88.4%


85.8%


89.6%

ABD, LTC & Medicare

94.9


89.1


94.0


89.6

Specialty Services

80.4


82.6


84.0


83.0

  Total

88.9


88.4


89.1


89.3









Total General & Administrative Expense Ratio

8.6%


8.9%


8.7%


8.6%




MEDICAL CLAIMS LIABILITY (In thousands)


The changes in medical claims liability are summarized as follows:


Balance, June 30, 2013


$

972,641

Incurred related to:



  Current period


10,541,171

  Prior period


(132,805)

Total incurred


10,408,366

Paid related to:



  Current period


9,171,457

  Prior period


815,435

Total paid


9,986,892

Balance, June 30, 2014


$

1,394,115

SOURCE Centene Corporation



More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.